Search Results - Nancy U Lin

Refine Results
  1. 1

    Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer by Stefania Morganti, Heather A. Parsons, Nancy U. Lin, Albert Grinshpun

    Published in npj Breast Cancer (2023-05-01)
    Get full text
    Article


  2. 2

    Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases by Stacey Pan, Jayant Y. Gadrey, Sarah Sammons, Nancy U. Lin, Sara M. Tolaney, Paolo Tarantino, Ilana Schlam

    Published in Therapeutic Advances in Medical Oncology (2024-11-01)
    Get full text
    Article


  3. 3

    Integrative multiomics-histopathology analysis for breast cancer classification by Yasha Ektefaie, William Yuan, Deborah A. Dillon, Nancy U. Lin, Jeffrey A. Golden, Isaac S. Kohane, Kun-Hsing Yu

    Published in npj Breast Cancer (2021-11-01)
    Get full text
    Article


  4. 4

    Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data by Nancy U. Lin, Priya Kumthekar, Solmaz Sahebjam, Nuhad Ibrahim, Anita Fung, Anna Cheng, Alan Nicholas, Jesse Sussell, Mark Pegram

    Published in npj Breast Cancer (2023-11-01)
    Get full text
    Article


  5. 5

    Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan by Laura Alder, Dario Trapani, Claire Bradbury, Amanda E. D. Van Swearingen, Sara M. Tolaney, Mustafa Khasraw, Carey K. Anders, Christopher D. Lascola, Liangge Hsu, Nancy U. Lin, Sarah Sammons

    Published in npj Breast Cancer (2023-03-01)
    Get full text
    Article


  6. 6

    Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer by Paolo Tarantino, Julieta Leone, Carlos T. Vallejo, Rachel A. Freedman, Adrienne G. Waks, Olga Martínez-Sáez, Ana Garrido-Castro, Filipa Lynce, Nabihah Tayob, Nancy U. Lin, Sara M. Tolaney, Jose P. Leone

    Published in npj Breast Cancer (2024-04-01)
    Get full text
    Article


  7. 7

    The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study by Kristen D. Brantley, Gregory J. Kirkner, Melissa E. Hughes, Leticia Varella, Georgia Suggs, Olivia M. Cunningham, Sanjana Ravikumar, Craig Snow, Sara M. Tolaney, Sarah Sammons, Ann H. Partridge, Nancy U. Lin

    Published in npj Breast Cancer (2025-08-01)
    Get full text
    Article


  8. 8

    Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases by Thomas Grinda, Stefania Morganti, Liangge Hsu, Tae-Kyung Yoo, Ross J. Kusmick, Ayal A. Aizer, Antonio Giordano, Jose P. Leone, Melissa Hughes, Sara M. Tolaney, Nancy U. Lin, Sarah L. Sammons

    Published in npj Breast Cancer (2025-03-01)
    Get full text
    Article


  9. 9

    Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science–Based... by Ashley J Housten, Uzoma Charles Okere, Graham A Colditz, Cynthia Ma, Jingxia Liu, Courtney Harriss, Nancy U Lin, Melissa Rooney, Jennifer Dill, Muhammad Popalzai, Jennifer Badiu, Kan Huang, Casey Burton, Lindsay Peterson

    Published in JMIR Research Protocols (2022-07-01)
    Get full text
    Article


  10. 10

    Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study by Adith Abraham, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Sarah Asad, Daniel G. Stover

    Published in Breast (2023-02-01)
    Get full text
    Article


  11. 11

    Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment by Christine M. Dang, Troy J. Kemp, Nancy Roche, Katarzyna Haynesworth, Sarah A. Loftus, Benjamin J. Borski, Ziad El Bakouny, Chris Labaki, Gwo-Shou Mary Lee, Rachel Trowbridge, Sarah Strauss, Melissa E. Hughes, Nancy U. Lin, Toni K. Choueiri, Ligia A. Pinto

    Published in Human Vaccines & Immunotherapeutics (2025-12-01)
    Get full text
    Article


  12. 12

    Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer by Albert Grinshpun, Douglas Russo, Wen Ma, Ana Verma, Francisco Hermida-Prado, Shira Sherman, Giorgio Gaglia, Sheheryar Kabraji, Gregory Kirkner, Melissa E. Hughes, Nancy U. Lin, Zachary Sandusky, Agostina Nardone, Cristina Guarducci, Quang-De Nguyen, Sandro Santagata, Zsuzsanna Nagy, Rinath Jeselsohn

    Published in npj Breast Cancer (2024-06-01)
    Get full text
    Article


  13. 13

    Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer by Ana C. Garrido-Castro, Meredith M. Regan, Samuel M. Niman, Faina Nakhlis, Claire Remolano, Jennifer M. Rosenbluth, Caroline Block, Laura E. Warren, Jennifer R. Bellon, Eren Yeh, Beth T. Harrison, Elizabeth Troll, Nancy U. Lin, Sara M. Tolaney, Beth Overmoyer, Filipa Lynce

    Published in npj Breast Cancer (2023-06-01)
    Get full text
    Article


  14. 14

    Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer by Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A. Mittendorf, Tari A. King, Anna Weiss, Ann H. Partridge, Brittany L. Bychkovsky, Giuseppe Curigliano, Nabihah Tayob, Nancy U. Lin, Judy E. Garber, Sara M. Tolaney, Filipa Lynce

    Published in npj Breast Cancer (2024-04-01)
    Get full text
    Article


  15. 15

    Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast c... by Erika P. Hamilton, Manish R. Patel, Virginia F. Borges, Jane L. Meisel, Meena Okera, Carlos A. Alemany, Timothy J. Pluard, Robert Wesolowski, Dhanusha Sabanathan, Kathy D. Miller, Alison K. Conlin, Nicole McCarthy, Morena Shaw, Margaret Tonda, Mark Shilkrut, Nancy U. Lin

    Published in Breast Cancer Research (2025-07-01)
    Get full text
    Article


  16. 16

    Osteopontin is a therapeutic target that drives breast cancer recurrence by Yu Gu, Tarek Taifour, Tung Bui, Dongmei Zuo, Alain Pacis, Alexandre Poirier, Sherif Attalla, Anne-Marie Fortier, Virginie Sanguin-Gendreau, Tien-Chi Pan, Vasilios Papavasiliou, Nancy U. Lin, Melissa E. Hughes, Kalie Smith, Morag Park, Michel L. Tremblay, Lewis A. Chodosh, Rinath Jeselsohn, William J. Muller

    Published in Nature Communications (2024-10-01)
    Get full text
    Article


  17. 17

    Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial by Jorge Gómez Tejeda Zañudo, Romualdo Barroso-Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle

    Published in Nature Communications (2024-03-01)
    Get full text
    Article


  18. 18

    Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer by Jennifer L. Guerriero, Jia-Ren Lin, Ricardo G. Pastorello, Ziming Du, Yu-An Chen, Madeline G. Townsend, Kenichi Shimada, Melissa E. Hughes, Siyang Ren, Nabihah Tayob, Kelly Zheng, Shaolin Mei, Alyssa Patterson, Krishan L. Taneja, Otto Metzger, Sara M. Tolaney, Nancy U. Lin, Deborah A. Dillon, Stuart J. Schnitt, Peter K. Sorger, Elizabeth A. Mittendorf, Sandro Santagata

    Published in npj Breast Cancer (2024-01-01)
    Get full text
    Article


  19. 19

    Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) by Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, Sangeetha M. Reddy, Leisha A. Emens, Thomas M. Kuntz, Carolina Alves Costa Silva, Saud H. AlDubayan, Hoyin Chu, Beth Overmoyer, Paulina Lange, Molly K. DiLullo, Meagan Montesion, Julie Kasparian, Melissa E. Hughes, Victoria Attaya, Ameer Basta, Nancy U. Lin, Nabihah Tayob, Rinath Jeselsohn, Elizabeth A. Mittendorf, Sara M. Tolaney

    Published in Nature Communications (2025-05-01)
    Get full text
    Article


  20. 20

    Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer by Paolo Tarantino, Hersh Gupta, Melissa E. Hughes, Janet Files, Sarah Strauss, Gregory Kirkner, Anne-Marie Feeney, Yvonne Li, Ana C. Garrido-Castro, Romualdo Barroso-Sousa, Brittany L. Bychkovsky, Simona DiLascio, Lynette Sholl, Laura MacConaill, Neal Lindeman, Bruce E. Johnson, Matthew Meyerson, Rinath Jeselsohn, Xintao Qiu, Rong Li, Henry Long, Eric P. Winer, Deborah Dillon, Giuseppe Curigliano, Andrew D. Cherniack, Sara M. Tolaney, Nancy U. Lin

    Published in Nature Communications (2023-11-01)
    Get full text
    Article


Search Tools: